Overview

Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
A Phase 1b/2, Randomized, Double-blind, Placebo-Controlled, Multiple Oral Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients with Dementia
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Intra-Cellular Therapies, Inc.